InMed Pharmaceuticals Inc. (IMLFF) Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D…

InMed Pharmaceuticals Inc. (IMLFF) to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business…

InMed Pharmaceuticals Inc. (IMLFF) to Present at the 31st Annual ROTH Conference on March 19, 2019

InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March…

 InMed Pharmaceuticals Inc. (IMLFF) to Report Second Quarter Fiscal 2019 Financial Results and Business Update

InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business…

InMed Pharmaceuticals (IMLFF) (IN) Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer

VANCOUVER, Jan. 11, 2019 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the…

$IMLFF Expands Pipeline with Initiation of Program Targeting Epidermolysis bullosa simplex

InMed Expands Pipeline with Initiation of Program Targeting Epidermolysis bullosa simplex (EBS)…